Literature DB >> 8004742

Mechanisms of inhibition of endothelium-dependent relaxation by halothane, isoflurane, and sevoflurane.

K Nakamura1, K Terasako, H Toda, I Miyawaki, M Kakuyama, M Nishiwada, Y Hatano, K Mori.   

Abstract

Volatile anaesthetics inhibit endothelium-dependent relaxation, but the underlying mechanism(s) have not been clarified. In an attempt to elucidate the mechanism(s), we determined the effects of halothane, isoflurane and sevoflurane on relaxation induced by acetylcholine and sodium nitroprusside (SNP) and the cGMP formation elicited by exogenous nitric oxide (NO) and SNP in rat aortas. Acetylcholine (10(-7)-10(-5) M)-induced relaxation was attenuated by halothane (2%), isoflurane (2%) and sevoflurane (4%). SNP (10(-8) M)-induced relaxation was reduced by halothane (2%), but not by isoflurane (2%) or sevoflurane (4%). The cGMP level of NO-stimulated aorta was reduced by halothane (2%) and sevoflurane (4%), but not by isoflurane (2%). The cGMP level of SNP (10(-7) M)-stimulated aorta was reduced by halothane (2%), but not by isoflurane (2%) and sevoflurane (4%). We conclude that the mechanisms responsible for the inhibition of endothelium-dependent relaxation differ among anaesthetics. Isoflurane inhibits the relaxation mainly by inhibiting the formation of NO in the endothelium. In contrast, the effect of halothane on endothelium-dependent relaxation may be largely due to the inhibition of action of NO in the vascular smooth muscle and the effect of sevoflurane may be to inactivate NO or to inhibit the action of NO.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8004742     DOI: 10.1007/BF03009915

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  17 in total

1.  Tension-induced release of endothelium-derived relaxing factor; possible role in establishment of desensitization of norepinephrine-induced contraction in rat aorta.

Authors:  T Nakaki; Y Otsuka; R Kato
Journal:  Jpn J Pharmacol       Date:  1990-12

2.  Minimum alveolar concentrations (MAC) of isoflurande with and without nitrous oxide in patients of various ages.

Authors:  W C Stevens; W M Dolan; R T Gibbons; A White; E I Eger; R D Miller; R H DeJong; R M Elashoff
Journal:  Anesthesiology       Date:  1975-02       Impact factor: 7.892

3.  Halothane, enflurane, and isoflurane attenuate both receptor- and non-receptor-mediated EDRF production in rat thoracic aorta.

Authors:  M J Uggeri; G J Proctor; R A Johns
Journal:  Anesthesiology       Date:  1992-06       Impact factor: 7.892

4.  An ultrasensitive method for the simultaneous determination of cyclic AMP and cyclic GMP in small-volume samples from blood and tissue.

Authors:  M Honma; T Satoh; J Takezawa; M Ui
Journal:  Biochem Med       Date:  1977-12

5.  Minimum alveolar concentrations of methoxyflurane, halothane, ether and cyclopropane in man: correlation with theories of anesthesia.

Authors:  L J Saidman; E I Eger; E S Munson; A A Babad; M Muallem
Journal:  Anesthesiology       Date:  1967 Nov-Dec       Impact factor: 7.892

6.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.

Authors:  R F Furchgott; J V Zawadzki
Journal:  Nature       Date:  1980-11-27       Impact factor: 49.962

7.  Comparison of the direct effects of sevoflurane, isoflurane and halothane on isolated canine coronary arteries.

Authors:  K Nakamura; H Toda; Y Hatano; K Mori
Journal:  Can J Anaesth       Date:  1993-03       Impact factor: 5.063

8.  Selective impairment of endothelium-dependent relaxation by sevoflurane: oxygen free radicals participation.

Authors:  K Yoshida; E Okabe
Journal:  Anesthesiology       Date:  1992-03       Impact factor: 7.892

9.  Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical.

Authors:  L J Ignarro; R E Byrns; G M Buga; K S Wood
Journal:  Circ Res       Date:  1987-12       Impact factor: 17.367

10.  Mechanism of inhibitory action of sodium nitroprusside in vascular smooth muscle of rabbit aorta.

Authors:  H Karaki; K Murakami; N Urakawa
Journal:  Arch Int Pharmacodyn Ther       Date:  1986-04
View more
  5 in total

Review 1.  Anesthesia and the quantitative evaluation of neurovascular coupling.

Authors:  Kazuto Masamoto; Iwao Kanno
Journal:  J Cereb Blood Flow Metab       Date:  2012-04-18       Impact factor: 6.200

Review 2.  Sevoflurane. A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia.

Authors:  S S Patel; K L Goa
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

3.  Sevoflurane inhibits angiotensin II-induced Rho kinase-mediated contraction of vascular smooth muscle from spontaneously hypertensive rat.

Authors:  Nobuhiko Uematsu; Koji Ogawa; Yasuyuki Tokinaga; Kazuaki Tange; Yoshio Hatano
Journal:  J Anesth       Date:  2011-03-16       Impact factor: 2.078

4.  The cellular mechanisms underlying the inhibitory effects of isoflurane and sevoflurane on arginine vasopressin-induced vasoconstriction.

Authors:  Manabu Shimogai; Koji Ogawa; Yasuyuki Tokinaga; Akinori Yamazaki; Yoshio Hatano
Journal:  J Anesth       Date:  2010-10-17       Impact factor: 2.078

5.  Pulsed ultrasound enhances the delivery of nitric oxide from bubble liposomes to ex vivo porcine carotid tissue.

Authors:  J T Sutton; J L Raymond; M C Verleye; G J Pyne-Geithman; C K Holland
Journal:  Int J Nanomedicine       Date:  2014-10-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.